About Snake River Research, PLLC
- Top Sponsors
- Top Collaborators
- Trials By Phase
- Recruitment Status
- Top Conditions
- Intervention Types
- Top Intervention Names
- Trials By Gender
Lead Sponsor
# Trials
Pfizer
6
Janssen Research & Development, LLC
3
Actelion
1
Aerpio Therapeutics
1
Bavarian Nordic
1
Bio-Thera Solutions
1
Crestone, Inc
1
Deinove
1
Finch Research and Development LLC.
1
First Wave BioPharma, Inc.
1
MGB Biopharma Limited
1
Clinical Trials at Snake River Research, PLLC
During the past decade, Snake River Research, PLLC conducted 23 clinical trials. In the 10-year time frame, 23 clinical trials started and 5 clinical trials were completed, i.e. on
average, 21.7% percent of trials that started reached the finish line to date. In the past 5 years, 13 clinical trials started and 4 clinical trials were completed. i.e. 30.8%
of trials that started reached the finish line.
Trials List
Trail ID
Brief Title
Start Date
Completion Date
Status
Enrollment
Safety and Efficacy of SA4Ag Vaccine in Adults Having Elective Open Posterior Spinal Fusion Procedures With Multilevel Instrumentation
2015-07-02
2019-06-27
Terminated
3,450
SER-262 Versus Placebo in Adults With Primary Clostridium Difficile Infection to Prevent Recurrence
2016-08-01
2018-08-01
Completed
96
Comparison of Cadazolid Versus Vancomycin in Children With Clostridium Difficile-associated Diarrhea (CDAD)
2017-04-14
2018-04-17
Terminated
1
A Retrospective Observational Study to Evaluate the Utilization, Outcomes, and Adverse Events in Participants Treated With Orbactiv® (Oritavancin) for Infections Caused by Gram Positive Bacteria in a Real World Setting
2017-04-12
2018-03-08
Completed
325
A Study to Evaluate the Efficacy and Safety of Pimodivir in Combination With the Standard-of-Care Treatment in Adolescent, Adult, and Elderly Non-Hospitalized Participants With Influenza A Infection Who Are at Risk of Developing Complications
2018-01-21
2020-08-24
Terminated
553
Study to Assess Safety, Tolerability and Efficacy of Incremental Doses of MGB-BP-3 in Patients With CDAD
2019-02-07
2020-04-03
Completed
34
Clostridium Difficile Vaccine 2-Dose Versus 3-Dose Study
2019-04-01
2020-12-22
Completed
1,994
Clinical Trials Sponsors and Collaborators
Out of the total clinical trials conducted in "Snake River Research, PLLC" #1 sponsor was "Pfizer" with 6 trials, followed by "Janssen Research & Development, LLC" with 3 trials
sponsored, "Actelion" with 1 trials sponsored, "Aerpio Therapeutics" with 1 trials sponsored and "Bavarian Nordic"
with 1 trials sponsored. Other sponsors include 6 different institutions and
companies that sponsored additional 16 trials in total.
In terms of collaborators to trials, out of the total clinical trials conducted in "Snake River Research, PLLC"
#1 collaborator was "Department of Health and Human Services" with 1 trials as a collaborator, "Medical Technology Enterprise Consortium (MTEC)" with 1 trials as a collaborator, "National Heart, Lung, and Blood Institute (NHLBI)" with 1 trials as a collaborator, "National Institute of Allergy and Infectious Diseases (NIAID)" with 1 trials as a collaborator and "Pharm-Olam International" with 1 trials as a collaborator. Other collaborators include -3 different institutions and companies that were
collaborators in the rest 7 trials.
Clinical Trials Conditions at Snake River Research, PLLC
According to Clinical.Site data, the most researched conditions in "Snake River Research, PLLC" are
"Clostridium Difficile Infection" (4 trials), "COVID-19" (3 trials), "Clostridioides Difficile Infection" (2 trials), "Covid19" (2 trials) and "Acute Respiratory Distress Syndrome" (1 trials). Many other conditions were trialed in "Snake River Research, PLLC" in a lesser frequency.
Clinical Trials Intervention Types at Snake River Research, PLLC
Most popular intervention types in "Snake River Research, PLLC" are "Drug" (13 trials), "Biological" (9 trials), "Other" (4 trials) and "Diagnostic Test" (1 trials). Other intervention types were less common.
The name of intervention was led by "Placebo" (12 trials), "13-valent pneumococcal conjugate vaccine" (1 trials), "20-valent pneumococcal conjugate vaccine" (1 trials), "Active Comparator" (1 trials) and "Apixaban 2.5 MG" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Snake River Research, PLLC
The vast majority of trials in "Snake River Research, PLLC" are
22 trials for "All" genders and 1 trials for "Female" genders.
Clinical Trials Status at Snake River Research, PLLC
Currently, there are NaN active trials in "Snake River Research, PLLC".
undefined are not yet recruiting,
4 are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 9 completed trials in Snake River Research, PLLC,
undefined suspended trials,
and 6 terminated clinical trials to date.
Out of the total trials that were conducted in Snake River Research, PLLC, 2 "Phase 1"
clinical trials were conducted, 10 "Phase 2" clinical
trials and 11 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 0 trials that are defined as “Not Applicable".